Don't let it drag on, here are 6 easy ways to deal with stress
The Food and Drug Administration (BPOM) has issued an emergency use of authorization (EUA) for the drug Avifavir for COVID-19. Although phase III clinical trials are still in progress, this drug is claimed to have high effectiveness in curing COVID-19 patients. After the Avigan drug, the BPOM officially gave an emergency permit for the use of avifavir for COVID-19. Because Avifavir's status is still EUA, BPOM is still monitoring the distribution of this drug, and evaluating its quality, quality, safety, and effectiveness. Getting to know Avifavir for COVID-19 The drug Avifavir is produced by Russian Direct Investment Fund (RDIF) and ChemRar Group from Russia. Since the beginning of June 2020, this drug has been supplied to all regions of Russia and 15 countries around the world. Indonesia became the first Asian country to register the drug Avifavir. The active ingredient of Avifavir is favipiravir, which is generally used to treat infections caused by several...